Education
About Us
Working with TipRanks
Follow Us
Agios Pharmaceuticals (AGIO)
NASDAQ:AGIO
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 36.50M | $ 26.82M | $ 14.24M | $ 0.00 | $ 0.00 |
| Gross Profit | $ 32.33M | $ 17.32M | $ 12.54M | $ -18.78M | $ -18.77M |
| Operating Income | $ -425.74M | $ -391.49M | $ -389.05M | $ -378.42M | $ -335.92M |
| EBITDA | $ -420.08M | $ -384.86M | $ -380.48M | $ -337.73M | $ -310.53M |
| Net Income | $ 673.73M | $ -352.09M | $ -231.80M | $ 1.60B | $ -327.37M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 893.71M | $ 776.93M | $ 783.12M | $ 1.02B | $ 572.93M |
| Total Assets | $ 1.66B | $ 937.12M | $ 1.24B | $ 1.44B | $ 852.95M |
| Total Debt | $ 56.99M | $ 72.00M | $ 85.66M | $ 97.09M | $ 105.20M |
| Net Debt | $ -19.26M | $ -16.21M | $ -53.60M | $ -106.03M | $ -22.24M |
| Total Liabilities | $ 122.24M | $ 126.10M | $ 137.90M | $ 145.76M | $ 453.45M |
| Stockholders' Equity | $ 1.54B | $ 811.02M | $ 1.10B | $ 1.29B | $ 399.50M |
| Cash Flow | |||||
| Free Cash Flow | $ -391.53M | $ -297.06M | $ -314.36M | $ -413.06M | $ -304.87M |
| Operating Cash Flow | $ -389.84M | $ -296.06M | $ -309.48M | $ -407.32M | $ -290.76M |
| Investing Cash Flow | $ 363.44M | $ 239.57M | $ 243.26M | $ 1.25B | $ 75.75M |
| Financing Cash Flow | $ 14.44M | $ 5.43M | $ 2.35M | $ -765.77M | $ 261.52M |